Pages that link to "Q33899144"

The following pages link to The introduction of new vaccines into developing countries II. Vaccine financing (Q33899144):

Displaying 22 items.

• Vaccine procurement during an influenza pandemic and the role of Advance Purchase Agreements: Lessons from 2009-H1N1. (Q30203064) (← links)
• Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline. (Q31152120) (← links)
• Factors Affecting the Introduction of New Vaccines to Poor Nations: A Comparative Study of the Haemophilus influenzae Type B and Hepatitis B Vaccines (Q33745105) (← links)
• Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan (Q33787759) (← links)
• The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan Africa (Q34432530) (← links)
• Predictors to parental knowledge about childhood immunisation/EPI vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13). (Q34496841) (← links)
• Pricing of new vaccines (Q34663970) (← links)
• Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001. (Q34737086) (← links)
• Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial [NCT00125047]. (Q34804222) (← links)
• Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia (Q34999848) (← links)
• The introduction of new vaccines into developing countries. IV: Global Access Strategies (Q36760789) (← links)
• A new approach to global health institutions? A case study of new vaccine introduction and the formation of the GAVI Alliance (Q37778612) (← links)
• The effect of social determinants on immunization programs (Q37983415) (← links)
• Combination vaccines in the South African setting (Q38039616) (← links)
• The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries? (Q38176451) (← links)
• Vaccines and IP Rights: A Multifaceted Relationship (Q39174034) (← links)
• Introduction of Hib vaccine into national immunization programmes: a descriptive analysis of global trends (Q40176358) (← links)
• Strengthening immunization systems and introduction of hepatitis B vaccine in central and eastern Europe and the newly independent states (Q44074553) (← links)
• Geneva-Seattle collaboration in support of developing country vaccine manufacturing (Q48769122) (← links)
• The prevalence and genotype of human papillomavirus on cervical samples from an Irish female population with external genital warts (Q51326606) (← links)
• The introduction of new vaccines into developing countries. III. The role of intellectual property (Q75325571) (← links)
• Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment (Q80335010) (← links)